Literature DB >> 18718284

Extraocular proprioception and new treatments for infantile nystagmus syndrome.

L F Dell'Osso1, Z I Wang.   

Abstract

Our goal is to develop the proprioceptive hypothesis for nystagmus damping; and present the resulting therapies for the treatment of infantile nystagmus syndrome (INS) and acquired nystagmus. Contact lenses, cutaneous stimulation, and neck-muscle vibration damped INS. Four-muscle tenotomy and reattachment was hypothesized as a treatment for INS in 1979 and successfully demonstrated to improve foveation in a canine model of INS and seesaw nystagmus in 1998 and in humans with INS (masked-data, NEI Clinical Trial) in 2003. Subsequently, tenotomy successfully damped acquired pendular nystagmus and oscillopsia in two MS patients and downbeat nystagmus in another. Tenotomy, used in isolation or combination with existing nystagmus and strabismus surgeries, damps different types of nystagmus in their plane of action. Recent neuroanatomical and neurophysiological discoveries support the hypothesis that proprioception is the mechanism for INS damping and allow more realistic models of peripheral ocular motor pathways.

Entities:  

Mesh:

Year:  2008        PMID: 18718284     DOI: 10.1016/S0079-6123(08)00610-9

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  3 in total

1.  Damping of monocular pendular nystagmus with vibration in a patient with multiple sclerosis.

Authors:  Shin C Beh; Ali Saber Tehrani; Amir Kheradmand; David S Zee
Journal:  Neurology       Date:  2014-03-14       Impact factor: 9.910

2.  Using the NAFX to measure the effectiveness over time of gene therapy in canine LCA.

Authors:  Jonathan B Jacobs; Louis F Dell'Osso; Zhong I Wang; Gregory M Acland; Jean Bennett
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-20       Impact factor: 4.799

3.  Origins of strabismus and loss of binocular vision.

Authors:  Emmanuel Bui Quoc; Chantal Milleret
Journal:  Front Integr Neurosci       Date:  2014-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.